Table 1.
Characteristic | Overall (n=30) |
No Evidence of CLS-B (n=16) |
CLS–B Demonstrated (n=14) |
---|---|---|---|
Age (years) | |||
Median (range) | 50 (26,70) | 48.5 (26, 70) | 51.5 (38, 68) |
Menopausal Status, n(%) | |||
Pre | 16 | 9 (56) | 7 (44) |
Post | 14 | 7 (50) | 7 (50) |
Body Mass Index | |||
Median (range) | 26.3 (19.3, 45.6) | 22.5 (19.3,35.7) | 29.2 (22.1, 45.6) |
BRCA Status, n (%) | |||
Known Mutation | 7 | 5 (71) | 2 (29) |
No Known Mutation | 9 | 6 (67) | 3 (33) |
Unknown | 14 | 5 (36) | 9 (64) |
Breast Surgery | |||
Ipsilateral Breast Cancer | 2 | 1 | 1 |
Contralateral Breast Cancer | 14 | 8 | 6 |
Carcinoma in Situ | 12 | 5 | 7 |
No Breast Cancer History | 2 | 2 | 0 |